M. Fragoso-Serrano et al. / Tetrahedron 62 (2006) 11916–11924
11923
aliquots of 20 mg (n-hexane–EtOAc, 1:1, flow rate¼6 mL/
min) to yield 3 (23.3 mg, 15.7%, tR¼15.5 min), 2a (50.0 mg,
36.6%, tR¼17.9 min), 2c (1.6 mg, 1.2%, tR¼21.8 min), and
2b (36.8 mg, 26.9%, tR¼26.8 min). Treatment of 1a
(100 mg) with acetyl chloride (5 mL) at room temperature
for 2 h followed by evaporation under a N2 flow and
HPLC purification gave 3 in better yields (73 mg, 49%).
d 171.5, 170.0, 169.6, 144.6, 143.8, 139.0, 130.3, 129.9,
123.2, 116.7, 73.5, 69.8, 69.0, 65.2, 20.9, 20.8, 20.7, 19.1;
FABMS m/z [M+H]+ 471, [M]+ 470, [MꢁC2H3O2]+ 411,
[MꢁC2H3O2ꢁ2C2H4O2]+ 291; HRFABMS m/z 471.1369
(calcd for C18H22N4O11+H, 471.1363).
4.1.2.4.2. 1-(2,3,4-Tri-O-acetyl-6-deoxy-a-L-mannopyra-
nosyl)-2-(2,4-dinitrophenyl)hydrazine (2c)
Yellow oil; IR (CHCl3) nmax 3575, 3557, 1790, 1731, 1604,
4.1.2.3. 1-(2,3,4-Tri-O-acetyl-6-deoxy-b-L-mannopyr-
anosyl)-2-(2,4-dinitrophenyl)hydrazine (2a). Yellow
prisms; mp 103–105 ꢀC; IR (CHCl3) nmax 3751, 3365, 1750,
1620, 1594, 1524, 1429, 1372, 1339, 1311, 1238, 1226,
1060, 926, 836 cmꢁ1; ORD (c 1.29, CHCl3) [a]589 +29,
[a]578 +29, [a]546 +31; 1H NMR (300 MHz, CDCl3) d 9.63
(1H, br s), 9.07 (1H, d, J¼2.7 Hz), 8.27 (1H, dd, J¼9.6,
2.7 Hz), 7.68 (1H, d, J¼9.6 Hz), 5.62 (1H, dd, J¼3.3,
1.2 Hz), 5.08 (1H, dd, J¼10.2, 9.3 Hz), 5.00 (1H, dd,
J¼3.3, 10.2 Hz), 4.52 (1H, d, J¼11.4 Hz), 4.40 (1H, dd,
J¼11.4, 1.2 Hz), 3.57 (1H, dq, 1H, J¼9.3, 6.3 Hz), 2.23,
2.08, 2.00 (3H each, 3s), 1.32 (3H, d, J¼6.3 Hz); 13C NMR
(75.4 MHz, CDCl3) d 170.1, 170.0, 169.8, 148.9, 137.3,
130.1, 129.7, 123.6, 115.6, 85.7, 72.1, 71.5, 70.1, 68.9,
20.7, 20.7, 20.5, 17.4; EIMS m/z (rel int.) [M]+ 470 (4), 411
(2), 306 (9), 291 (10), 273 (17), 213 (8), 193 (9), 171 (20),
153 (73), 129 (11), 111 (69), 83 (25), [C2H3O]+ 43 (100);
HREIMS m/z 470.1270 (calcd for C18H22N4O11, 470.1285).
1487, 1466, 1445, 1390, 1294, 1246, 1103, 1063, 975 cmꢁ1
;
ORD (c 0.15, CHCl3) [a]589 ꢁ19, [a]578 ꢁ20, [a]546 ꢁ22;
1H NMR (300 MHz, CDCl3) d 9.50 (1H, s), 9.11 (1H, d,
J¼2.5 Hz), 8.31 (1H, dd, J¼9.3, 2.5 Hz), 7.66 (1H, d,
J¼9.3 Hz), 5.29 (1H, dd, J¼7.1, 4.1 Hz), 5.26 (1H, dd, J¼
5.8, 4.1 Hz), 4.98 (1H, dd, J¼5.8, 5.0 Hz), 4.72 (1H, dd,
J¼6.9, 5.0 Hz), 4.44 (1H, d, J¼7.1 Hz), 4.11 (1H, quint, J¼
6.9 Hz), 2.15, 2.12, 2.09 (3H each, 3s), 1.36 (3H, d,
J¼6.9 Hz); 13C NMR (75.4 MHz, CDCl3) d 169.9, 169.6,
169.6, 149.3, 137.5, 130.2, 129.7, 123.8, 115.4, 83.9, 71.1,
70.3, 68.9, 66.8, 20.9, 20.8, 20.7, 16.9; EIMS m/z (rel int.)
[M]+ 470 (1), 446 (1), 306 (9), 291 (11), 273 (14), 213 (5),
193 (5), 171 (11), 153 (41), 129 (8), 111 (33), 83 (11),
[C2H3O]+ 43 (100); HREIMS m/z 470.1273 [M]+ (calcd
for C18H22N4O11, 470.1285).
4.1.2.4.3. 2,3,4,5-Tetra-O-acetyl-6-deoxy-L-mannose
2,4-dinitrophenylhydrazone (3)
Yellow oil; IR (CHCl3) nmax 3309, 1746, 1619, 1594, 1509,
4.1.2.4. X-ray analysis of 2a. The crystal
(0.22ꢂ0.25ꢂ0.46 mm) was obtained from EtOAc–hexane.
1437, 1373, 1340, 1235, 1147, 1062, 1038, 924, 837 cmꢁ1
;
It was monoclinic, space group C2, with a¼21.017(2),
ORD (c 1.14, CHCl3) [a]589 ꢁ14, [a]578 ꢁ15, [a]546 ꢁ17;
1H NMR (300 MHz, CDCl3) d 11.08 (1H, s), 9.12 (1H,
d, J¼2.5 Hz), 8.35 (1H, dd, J¼9.5, 2.5 Hz), 7.96 (1H,
d, J¼9.5 Hz), 7.35 (1H, dd, J¼6.0, 1.0 Hz), 5.58 (1H, dd,
J¼8.0, 3.0 Hz), 5.50 (1H, dd, J¼8.0, 6.0 Hz), 5.36 (1H,
dd, J¼8.5, 3.0 Hz), 5.04 (1H, dq, J¼8.5, 6.5 Hz), 2.12
(3H, s), 2.12 (3H, s), 2.06 (3H, s), 2.04 (3H, s), 1.24 (3H,
d, J¼6.5 Hz); 13C NMR (75.4 MHz, CDCl3) d 169.9,
169.9, 169.8, 169.4, 144.6, 144.0, 138.9, 130.1, 129.8,
123.1, 116.7, 70.9, 69.8, 68.7, 66.8, 21.0, 20.7, 20.7,
20.6, 16.3; EIMS (20 eV) m/z (rel int.) [M]+ 512 (0.1),
[MꢁC2H3O2]+ 453 (1), [453ꢁ2C2H4O2]+ 333 (2),
[333ꢁC2H2O]+ 291 (10), 290 (14), 251 (16), 129 (10), 117
(10), 111 (11), [C2H3O]+ 43 (100); FABMS m/z [M+Na]+
535; HRFABMS m/z 535.1288 [M+Na]+ (calcd for
C20H24N4O12+Na 535.1286).
3
˚
˚
b¼8.154(2), c¼13.591(2) A, cell volume¼2254.6 (7) A ,
rcalcd¼1.386 g/cm3 for Z¼4, MW¼470.40, and F(000)eꢁ¼
984. The intensity data were measured using Mo Ka radia-
˚
tion (l¼0.71073 A). Reflections, measured at 293 K within
a 2q range of 1.55–26.99ꢀ, were corrected for background,
Lorentz polarization, and absorption (m¼0.116 mmꢁ1),
while crystal decay was negligible. The structure was solved
by direct methods. For the structural refinement the non-
hydrogen atoms were treated anisotropically, and the hydro-
gen atoms, included in the structure factor calculation,
were refined isotropically. Final discrepancy indices were
RF¼5.65% and RW¼13.08% using a unit weight for 2947
reflections and refining 306 parameters. The final difference
Fourier map was essentially featureless, the highest residual
peaks having densities of 0.164 e/A3. Crystallographic data
for 2a have been deposited with the Cambridge Crystallo-
graphic Data Centre. Copies of the data can be obtained,
free of charge, on application to The Director, CCDC, 12
Union Road, Cambridge CB2 1EZ, UK. Fax: +44 1223
4.1.3. Molecular modeling calculations. Geometry optimi-
zations were carried out using the MMFF94 force-field cal-
culations as implemented in the Spartan’04 program.23 The
systematic conformational search for the pyranoside rings
was achieved with the aid of Dreiding models considering
torsion angle movements of ca. 30ꢀ. The EMMFF values were
used as the convergence criterion and a further search with
the Monte Carlo protocol was carried without considering
energy cut off. All local minima were geometry optimized
by DFT at the B3LYP/6-31G(d) level using the Spartan’04
routines. The Altona equation was used to calculate vicinal
couplings from dihedral angles for each conformer.
Gaussian 03W24 were used to calculate the 13C NMR chem-
ical shifts at the B3LYP/6-31G(d,p) level. The thermo-
chemical parameters DE0, DE298, DH298, and DS298 were
calculated at the same level considering vibrational frequen-
cies at 298.15 K and 1 atm. These values were used for
4.1.2.4.1. 2,3,4,-Tri-O-acetyl-6-deoxy-L-mannose 2,4-di-
nitrophenylhydrazone (2b)
Yellow oil; IR (CHCl3) nmax 3559, 3363, 1748, 1619, 1594,
1526, 2511, 1425, 1372, 1342, 1312, 1246, 1138, 1063,
924 cmꢁ1; ORD (c 0.66, CHCl3) [a]589 +14, [a]578 +14,
1
[a]546 +17; H NMR (300 MHz, CDCl3) d 11.10 (1H, s),
9.12 (1H, d, J¼2.5 Hz), 8.37 (1H, dd, J¼9.3, 2.5 Hz), 7.91
(1H, d, J¼9.3 Hz), 7.43 (1H, br d, J¼5.2 Hz), 5.79 (1H,
dd, J¼8.5, 1.9 Hz), 5.54 (1H, dd, J¼8.5, 5.2 Hz), 5.11
(1H, dd, J¼8.5, 1.9 Hz), 3.72 (1H, ddq, J¼8.5, 6.1,
4.9 Hz), 2.81 (1H, d, J¼4.9 Hz), 2.13, 2.12, 2.10 (3H each,
3s), 1.20 (3H, d, J¼6.1 Hz); 13C NMR (75.4 MHz, CDCl3)